NFCA Research on Gluten in Medications

The National Foundation for Celiac Awareness (NFCA) has received a grant from the Food and Drug Administration (FDA) to fund the first scientific research in the area of gluten in medication. The project entitled, “Gluten in Medication: Qualifying the Extent of Exposure to People with Celiac Disease and Identifying a Hidden and Preventable Cause of an Adverse Drug Event,” will characterize the problem of unlabeled gluten in medication and raise awareness of the potential harm that can occur to patients who ingest medications that they do not recognize as containing gluten, a protein found in wheat, barley, rye and their various derivatives. Although gluten may be included in excipients used in medications, there currently are no regulations requiring drug manufacturers to label the source of excipients used in their prescription or over-the-counter (OTC) medications. To date, there has been no scientific research conducted to determine if the amount of gluten that is in medication results in harm to people with celiac disease or gluten sensitivity, although there are reports of significant patient reactions to gluten in medication. This preliminary research aims to validate or nullify the anecdotal adverse experiences associated with gluten in medications that are reported by the celiac and gluten sensitive patient population. Findings from this project will provide a foundation for future investigation within the FDA and scientific communities, through which additional research, labeling, and safe use guideline initiatives can advance. Information about this grant can be found at: Click Here